A microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma
O'Rourke, Stephen T.
Li, David W.
Wu, Joseph M.
Taylor, Michael D.
Wu, ErxiNote: Order does not necessarily reflect citation order of authors.
MetadataShow full item record
CitationWang, F., M. Remke, K. Bhat, E. T. Wong, S. Zhou, V. Ramaswamy, A. Dubuc, et al. 2015. “A microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma.” Oncotarget 6 (5): 2709-2724.
AbstractOver-expression of PDGF receptors (PDGFRs) has been previously implicated in high-risk medulloblastoma (MB) pathogenesis. However, the exact biological functions of PDGFRα and PDGFRβ signaling in MB biology remain poorly understood. Here, we report the subgroup specific expression of PDGFRα and PDGFRβ and their associated biological pathways in MB tumors. c-MYC, a downstream target of PDGFRβ but not PDGFRα, is involved in PDGFRβ signaling associated with cell proliferation, cell death, and invasion. Concurrent inhibition of PDGFRβ and c-MYC blocks MB cell proliferation and migration synergistically. Integrated analysis of miRNA and miRNA targets regulated by both PDGFRβ and c-MYC reveals that increased expression of JAG2, a target of miR-1280, is associated with high metastatic dissemination at diagnosis and a poor outcome in MB patients. Our study may resolve the controversy on the role of PDGFRs in MB and unveils JAG2 as a key downstream effector of a PDGFRβ-driven signaling cascade and a potential therapeutic target.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:16121004
- HMS Scholarly Articles